与IPF患者不干预抗纤维素剂相关的因素
Maki Asami-Noyama1, Kazuki Hamada2, Yoshiyuki Asai3
1Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.
Respiratory investigation
|October 3, 2024
概括
许多具有良好表现状态 (PS) 的异形性肺纤维化 (IPF) 患者没有使用抗纤维剂治疗. 非干预与一般医院的症状较轻而易举,突出需要改善护理协调.
科学领域:
- 肺部病理学 肺部病理学
- 纤维化间歇性肺病 纤维化间歇性肺病
- 现实世界的证据.
背景情况:
- 在异形性肺纤维化 (IPF) 中抗纤维化剂的有效性已确立.
- 建议及早引入抗纤维素疗法,特别是在维持性能的患者 (PS).
研究的目的:
- 使用现实世界的数据来确定未经治疗的IPF病例的比例.
- 确定与IPF患者不干预相关的因素.
主要方法:
- 一项前性观察性研究,涉及518名患有间歇性肺病 (ILD) 的患者及其医生.
- 通过有关症状,表现状况,诊断和治疗选择的问卷收集的数据.
- 主要成分分析 (PCA) 用于分析影响治疗决策的因素.
主要成果:
- 包括207名IPF患者; 130名 (77.4%) 具有良好的PS (≤2) 没有接受抗纤维素药物.
- 治疗干预率因设施而异:一般医院的比例为16%,第三级呼吸中心的比例为62%.
- 在普通医院,较轻的症状 (良好的PS,低的mMRC,没有长期氧气治疗) 与不干预有关 (p < 0.001).
结论:
- 对于具有良好的PS的IPF患者,抗纤维素治疗的开始因医疗机构而异.
- 患有较轻度IPF症状的患者在普通医院治疗不足.
- 一般医院和专科中心之间的加强合作对于及时的抗纤维素治疗至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
669
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
669
Factors Affecting Protein-Drug Binding: Drug Interactions
727
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
727
Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
Chronic Inflammation: Introduction
41
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
41


